NVO
equitynet buyingNovo Nordisk A/S · OMX NORDIC EXCHANGE COPENHAGEN A/S
Buy it with play money
Fills at the latest stored close and lands in your paper portfolio
Sign in to buy NVO with $10,000 of play money and watch it from here.
Sign in to tradePrice, and when Congress traded it
Hollow marks where they traded, filled where the filing went public
Hover a marker to see who traded and what it was worth.
If you had bought it yourself
Paid at that day's close, held ever since. No member involved.
Working it out…
Short interest
Shares sold short, as brokers report them to FINRA twice a month
| Settlement date | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 31.62M | +20.1% | 1.7 |
| Sep 15, 2026 | 26.34M | -16.8% | 2.9 |
| Aug 31, 2026 | 31.65M | -6.4% | 2.7 |
| Aug 14, 2026 | 33.83M | +15.0% | 2.2 |
| Jul 31, 2026 | 29.42M | -5.4% | 2.9 |
| Jul 15, 2026 | 31.09M | +11.9% | 3.3 |
| Jun 30, 2026 | 27.78M | +13.5% | 2.2 |
| Jun 15, 2026 | 24.48M | +7.9% | 1.7 |
Largest fails to deliver, the last year
106 settlement days with at least $10,000 of shares sold and not delivered
| Settlement date | Shares | Value |
|---|---|---|
| Oct 20, 2025 | 941.2K | $51.2M |
| Feb 25, 2026 | 1.26M | $48.4M |
| Feb 23, 2026 | 680.66K | $32.3M |
| Jan 21, 2026 | 518.72K | $31.5M |
| Aug 17, 2026 | 637.8K | $29.3M |
Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.
What they lobby on
Disclosed to the Senate, largest spend first
- NOVO NORDISK INC.$1.3M
Health Issues, Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Tariff (miscellaneous tariff bills)
2nd Quarter (Apr 1 - June 30) 2026
- NOVO NORDISK INC.$1.3M
Health Issues, Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Tariff (miscellaneous tariff bills)
1st Quarter (Jan 1 - Mar 31) 2026
- BALLARD PARTNERS$120K
Pharmacy
2nd Quarter (Apr 1 - June 30) 2026
- BALLARD PARTNERS$120K
Pharmacy
1st Quarter (Jan 1 - Mar 31) 2026
- CHECKMATE GOVERNMENT RELATIONS$90K
Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
- CHECKMATE GOVERNMENT RELATIONS$90K
Health Issues
2nd Quarter (Apr 1 - June 30) 2026
- NVG, LLC$80K
Medicare/Medicaid, Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
- THE NICKLES GROUP, LLC$80K
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
2nd Quarter (Apr 1 - June 30) 2026
More on NVO
Who traded it
Most active first
Every disclosure
41 in total, newest first
Follow Novo Nordisk A/S (NVO) by email
New trades in Novo Nordisk A/S (NVO) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.